ClinicalTrials.gg
Status unknownNCT04035551HEALTHUpdated Jun 22, 2022

Health Evaluation And Learning for Total Parenteral Nutrition (TPN) at Home Patient Registry

An observational study in Malnutrition and Patients Requiring Home Parenteral Nutrition, sponsored by Coram Clinical Trials. Status unknown at 1 site in United States. Per ClinicalTrials.gov, last updated 2022-06-22.

Sponsored by Coram Clinical Trials · Observational

The sponsor has not verified this record recently (last verified Mar 2022), so the status shown — last known as Active, not recruiting — may be out of date.
Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
1,700
Sex
All
01

Study summary

The HEALTH Registry is a prospective, observational, non-interventional registry study of patients receiving home parenteral nutrition therapy in the US for a variety of indications.

Read the detailed description

The objective of the HEALTH Patient Registry is to establish and track therapy utilization and outcomes of patients receiving home parenteral nutrition therapy. Data collected will include information on patient safety, clinical outcomes, resource utilization and health-related quality of life (QOL). The goals of this Registry include:

  • To better understand the patients and populations requiring HPN in the U.S.
  • To measure clinical outcomes associated with HPN
  • To identify areas for focused quality improvement interventions
  • To provide opportunity for resource allocation identification and improvement
02

Conditions studied

  • Malnutrition
  • Patients Requiring Home Parenteral Nutrition

Browse trials for

Keywords

  • Home
  • HPN
  • Homecare
03

In context

Malnutrition

1,619 studies on the registry are indexed under Malnutrition; 241 are open to participants now.

This study's planned enrollment of 1,700 is above the median of 206 across 401 observational studies indexed under Malnutrition.

Browse Malnutrition studies →

Lead sponsor

Coram Clinical Trials is the lead sponsor of 4 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The HEALTH Registry program will collect data representative of patients receiving total parenteral nutrition (TPN) in the homecare setting.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patient of any age, gender, and indication referred to Coram/CVS Specialty Infusion Services to receive HPN in an alternate site of care, such as the home or infusion suite
  • Patient must be managed by Coram/CVS Specialty Infusion Services
  • The patient or the patient's caregiver must be willing to receive care and comply with the teaching and training necessary to administer treatment

Exclusion criteria

Exclusion Criteria:

  • Patient is unable to start, or stops receiving HPN
  • Patient is NOT managed by Coram/CVS Specialty Infusion Services
  • A patient and/or a patient's insurance will not cover cost of HPN therapy with Coram/CVS, or a patient elects not to start treatment
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
1,700 participants (estimated)
Target follow-up
3 Years
Patient registry
Yes

Groups and cohorts

  • patients receiving home parenteral nutrition

    Includes patients receiving home parenteral nutrition for any indication.

06

What researchers measure

Primary outcomes

  1. Change in Quality of Life over time: The Short Form (36)

    To examine the effect of HPN support on quality of life (functional health and well-being) as measured by The Short Form (36) Health Survey (SF-36v2). Physical component summary (PCS) and mental component summary (MCS) scores on a scale of 0 to 100 with higher scores reflecting better outcomes will be utilized.

    Time frame: At baseline and every 6 months during therapy through study completion, up to 3 years

  2. Efficacy of Home Parenteral Nutrition defined as the percentage of patients reaching their PN therapy goals

    The therapy goals (i.e. weight gain, weight loss, weight maintenance, resolution of GI issue, etc). will be recorded at study start. Percentage of patients reaching their designated therapy goal will be recorded (presented as a single percentage of patients that successful reached any therapy goal)

    Time frame: through study completion, an average of 3 years

Secondary outcomes

  1. Catheter-related infections

    Determine rate of catheter-related blood stream infections (CRBSIs) ( per 1000 catheter days)

    Time frame: through study completion, an average of 3 years

  2. Number of hospital readmissions and ER visits

    Assess number of hospital readmissions and visits to the ER

    Time frame: through study completion, an average of 3 years

  3. Mortality rate

    Number of study participants who expired during therapy

    Time frame: through study completion, an average of 3 years

07

Study locations

1 site
  • Coram CVS Specialty Infusion Services
    Centennial, Colorado 80112, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 22, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04035551
Lead sponsor
Coram Clinical Trials
Responsible party
Sponsor
First posted
Jul 29, 2019
Start date
Jun 17, 2019
Primary completion
Jul 1, 2023 (estimated)
Completion
Jul 1, 2024 (estimated)
Last update
Jun 22, 2022

Study contacts

Mark DeLegge, MD
principal investigator · Coram

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion